Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review.
Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review.
复制标题
DOI：
10.1016/j.jaccao.2022.03.005
复制
发表时间：
2022-06
影响因子：
11.1
通讯作者：
Dent, Susan
中科院分区：
文献类型：
--
作者：
Zullig, Leah L.;Sung, Anthony D.;Khouri, Michel G.;Jazowski, Shelley;Shah, Nishant P.;Sitlinger, Andrea;Blalock, Dan, V;Whitney, Colette;Kikuchi, Robin;Bosworth, Hayden B.;Crowley, Matthew J.;Goldstein, Karen M.;Klem, Igor;Oeffinger, Kevin C.;Dent, Susan
关键词：
美国有近1700万癌症幸存者，包括目前正在接受癌症治疗并有望成为长期幸存者的人，以及患有转移性疾病或慢性淋巴细胞白血病等慢性癌症、将接受多年癌症治疗的人。目前的临床实践指南侧重于生活方式干预，例如锻炼和健康饮食习惯，但通常不涉及临床医生的管理策略或提高药物依从性的策略。我们讨论了癌症幸存者中的 3 种心脏代谢合并症，并介绍了癌症诊断前合并症的患病率、癌症治疗期间合并症的治疗以及长期癌症幸存者或慢性癌症治疗者合并症的管理注意事项。讨论了支持药物依从性的方法和增强团队方法的潜在方法，以优化癌症患者在整个疾病过程中的护理。癌症幸存者患多种慢性疾病的风险增加，包括高血压、血脂异常和糖尿病。确定癌症患者合并症的最佳治疗方案至关重要。建议在积极的癌症治疗和生存的整个过程中采用多学科护理方法。生存研究应侧重于药物依从性和护理协调。
There are nearly 17 million cancer survivors in the United States, including those who are currently receiving cancer therapy with curative intent and expected to be long-term survivors, as well as those with chronic cancers such as metastatic disease or chronic lymphocytic leukemia, who will receive cancer therapy for many years. Current clinical practice guidelines focus on lifestyle interventions, such as exercise and healthy eating habits, but generally do not address management strategies for clinicians or strategies to increase adherence to medications. We discuss 3 cardiometabolic comorbidities among cancer survivors and present the prevalence of comorbidities prior to a cancer diagnosis, treatment of comorbidities during cancer therapy, and management considerations of comorbidities in long-term cancer survivors or those on chronic cancer therapy. Approaches to support medication adherence and potential methods to enhance a team approach to optimize care of the individual with cancer across the continuum of disease are discussed. Cancer survivors are at increased risk for several chronic conditions, including hypertension, dyslipidemia, and diabetes. Determining optimal management of comorbidities for patients with cancer is critical. A multidisciplinary care approach is recommended throughout the continuum of active cancer treatment and survivorship. Survivorship research should focus on medication adherence and coordination of care.
登录
查看更多内容
DOI：
10.2337/cd18-0105
发表时间：
2019-01-01
期刊：
Clinical diabetes : a publication of the American Diabetes Association
影响因子：
--
作者：
通讯作者：
--
影响因子：
3.8
作者：
Blaes A;Beckwith H;Florea N;Hebbel R;Solovey A;Potter D;Yee D;Vogel R;Luepker R;Duprez D
通讯作者：
Duprez D
影响因子：
45.3
作者：
Armenian, Saro H.;Lacchetti, Christina;Lenihan, Daniel
通讯作者：
Lenihan, Daniel
影响因子：
20.3
作者：
Armenian, Saro H.;Sun, Can-Lan;Bhatia, Smita
通讯作者：
Bhatia, Smita
DOI：
10.1007/s11764-018-0716-6
发表时间：
2018-12
期刊：
Journal of cancer survivorship : research and practice
影响因子：
--
作者：
Banegas MP;Emerson MA;Adams AS;Achacoso NS;Chawla N;Alexeeff S;Habel LA
通讯作者：
Habel LA